Tirzepatide 抗肥胖和胰岛素抵抗 : 病理生理方面和临床证据。
关键词: GIP GLP - 1 Tirzepatide arterial hypertension clinical trials insulin-resistance obesity pathophysiology
Mesh : Humans Obesity / drug therapy complications metabolism Insulin Resistance Diabetes Mellitus, Type 2 / drug therapy complications metabolism Animals Glucagon-Like Peptide-2 Receptor Gastric Inhibitory Polypeptide
来 源:
DOI:10.3389/fendo.2024.1402583
PDF(Pubmed)